Álvarez-López, I; Bezares, S; Portulas, EDalmau; García-Martínez, Elena; García-Saenz, JA; Gil-Gil, M; Martínez-de-Duenas, E; Ribelles, N; Santaballa-Bertran, A
(SPRINGER INT PUBL AG, 2020-08)
PURPOSE: Hormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being ...